SOCIETY OF VASCULAR AND INTERVENTIONAL NEUROLOGY (EIN 223941545) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

THANH NGUYEN

Phone

3126735832

Tax Period

2024-01-01 to 2024-12-31

SOCIETY OF VASCULAR AND INTERVENTIONAL NEUROLOGY, founded in 2006, is a community nonprofit in the Medical Research sector that reported $1.1M in total revenue in fiscal year 2018. Revenue surged 25% from the prior year, signaling strong growth momentum. Expenses of $970K left a modest 11% surplus.

Mission

TO REPRESENT THE ADVANCEMENT OF INTERVENTIONAL NEUROLOGY AS A FIELD WITH THE ULTIMATE GOAL OF IMPROVING CLINICAL CARE AND OUTCOMES OF PATIENTS WITH STROKE AND CEREBROVASCULAR DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $11,350

Program Service Revenue $2,677,120

Investment Income $39,011

Other Revenue $-3,139

TOTAL REVENUE $2,724,342

Expense Breakdown

Grants Paid $80,760

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,731,690

Other Expenses $2,318,854

TOTAL EXPENSES $2,399,614

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,724,342	$2,295,859	+0.2%
Expenses	$2,399,614	$2,405,758	0.0%
Net Income	$324,728	$-109,899	-4.0%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

250

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AMEER HASSAN DO	IMMEDIATE PAST PRESIDENT	5.00	Officer Director	$0	$0	$0
THANH NGUYEN MD	PRESIDENT	8.00	Officer Director	$0	$0	$0
SANTIAGO ORTEGA-GUTIERREZ MD	PRESIDENT-ELECT	4.00	Officer Director	$0	$0	$0
GABOR TOTH MD DIRECTOR	SECRETARY	2.00	Officer Director	$0	$0	$0
FAWAZ AL-MUFTI MD DIRECTOR	TREASURER	2.00	Officer Director	$0	$0	$0
SUNIL SHETH MD	DIRECTOR	1.00	Director	$0	$0	$0
KAIZ S ASIF MD	DIRECTOR	2.00	Director	$0	$0	$0
ALEXANDRA L CZAP MD	DIRECTOR	2.00	Director	$0	$0	$0
MOHAMMAD EL-GHANEM MD	DIRECTOR	1.00	Director	$0	$0	$0
PRIYANK KHANDELWAL MD	DIRECTOR	1.00	Director	$0	$0	$0
ALHAMZA AL-BAYATI MD	DIRECTOR	1.00	Director	$0	$0	$0
MOUHAMMAD JUMAA MD	DIRECTOR	1.00	Director	$0	$0	$0
CYNTHIA KENMUIR MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
MAY NOUR MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
JAMES SIEGLER MD	DIRECTOR	1.00	Director	$0	$0	$0
CATHERINE GAHRES	EXECUTIVE DIRECTOR THROUGH APRIL	20.00	Officer	$0	$0	$0
JOYCE PASCHALL	EXECUTIVE DIRECTOR AS OF DECEMBER	20.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,724,342	$2,399,614	$2,309,636	$324,728
2023	$2,295,859	$2,405,758	$1,491,954	$-109,899
2022	$2,655,499	$2,355,253	$2,281,947	$300,246
2021	$1,964,716	$1,965,971	$1,967,541	$-1,255
2020	$743,869	$1,025,707	$1,340,151	$-281,838
2019	$1,145,619	$1,064,842	$1,622,032	$80,777
2018	$1,084,105	$969,689	$1,396,575	$114,416

SOCIETY OF VASCULAR AND INTERVENTIONAL NEUROLOGY